These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8484504)

  • 1. Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?
    Kharasch ED; Thummel KE
    Anesth Analg; 1993 May; 76(5):1033-9. PubMed ID: 8484504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions.
    Kharasch ED; Russell M; Mautz D; Thummel KE; Kunze KL; Bowdle A; Cox K
    Anesthesiology; 1997 Jul; 87(1):36-50. PubMed ID: 9232132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED; Thummel KE
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
    Labroo RB; Thummel KE; Kunze KL; Podoll T; Trager WF; Kharasch ED
    Drug Metab Dispos; 1995 Apr; 23(4):490-6. PubMed ID: 7600917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics.
    Patten CJ; Thomas PE; Guy RL; Lee M; Gonzalez FJ; Guengerich FP; Yang CS
    Chem Res Toxicol; 1993; 6(4):511-8. PubMed ID: 8374050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
    Labroo RB; Paine MF; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance.
    Yun CH; Wood M; Wood AJ; Guengerich FP
    Anesthesiology; 1992 Sep; 77(3):467-74. PubMed ID: 1519785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic determinants of human liver microsomal alfentanil metabolism and the role of cytochrome P450 3A5.
    Klees TM; Sheffels P; Thummel KE; Kharasch ED
    Anesthesiology; 2005 Mar; 102(3):550-6. PubMed ID: 15731592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoflurane: a comparison of its metabolism by human and rat hepatic cytochrome P-450.
    Bradshaw JJ; Ivanetich KM
    Anesth Analg; 1984 Sep; 63(9):805-13. PubMed ID: 6465574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
    Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
    FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearance.
    Kharasch ED; Jubert C; Senn T; Bowdle TA; Thummel KE
    J Clin Pharmacol; 1999 Jul; 39(7):664-9. PubMed ID: 10392320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic cytochrome P450 induction in goats. Effects of model inducers on the metabolism of alkoxyresorufins, testosterone and ethylmorphine, and on apoprotein and mRNA levels.
    van't Klooster GA; Horbach GJ; Natsuhori M; Blaauboer BJ; Noordhoek J; van Miert AS
    Biochem Pharmacol; 1993 Jan; 45(1):113-22. PubMed ID: 8424805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
    Spracklin DK; Thummel KE; Kharasch ED
    Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 catalyzed metabolism of 1,2-dibromoethane in liver microsomes of differentially induced rats.
    Wormhoudt LW; Ploemen JH; Commandeur JN; van Ommen B; van Bladeren P; Vermeulen NP
    Chem Biol Interact; 1996 Jan; 99(1-3):41-53. PubMed ID: 8620578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of cyclosporine after orthotopic liver transplantation.
    Fabre JM; Pedrosa R; Bonardet A; Pichard L; Descomps B; Domergue J; Baumel H; Maurel P
    Biochem Pharmacol; 1993 Oct; 46(7):1151-7. PubMed ID: 8216365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
    Baker MT; Vasquez MT; Chiang CK
    Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil.
    Guitton J; Buronfosse T; Désage M; Lepape A; Brazier JL; Beaune P
    Biochem Pharmacol; 1997 Jun; 53(11):1613-9. PubMed ID: 9264313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of chick embryo hepatic cytochrome P450 1A, 2H and 3A following in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone.
    McNamee JP; Kimmett SM; Marks GS
    Biochem Pharmacol; 1995 May; 49(10):1443-52. PubMed ID: 7763287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.